Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study

Keta Vagha; Amar Taksande; Sneha Kenjale; Jayant Vagha; Ashish Varma

doi:10.7759/cureus.33373

journal article Jan 04, 2023

Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study

Keta Vagha Amar Taksande Sneha Kenjale Jayant Vagha Ashish Varma

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.33373

Topics

No keywords indexed for this article. Browse by subject →

References

18

[1]

The incidence of congenital heart disease

Julien I.E Hoffman, Samuel Kaplan

Journal of the American College of Cardiology 2002 10.1016/s0735-1097(02)01886-7

[2]

Dittrich H, Bührer C, Grimmer I, Dittrich S, Abdul-Khaliq H, Lange PE. Neurodevelopment at 1 year of age in infants with congenital heart disease. Heart. 2003, 89:436-41. 10.1136/heart.89.4.436 10.1136/heart.89.4.436

[3]

Wernovsky G, Licht DJ. Neurodevelopmental outcomes in children with congenital heart disease-what can we impact?. Pediatr Crit Care Med. 2016, 17:S232-42. 10.1097/PCC.0000000000000800 10.1097/pcc.0000000000000800

[4]

Rollins CK, Newburger JW, Roberts AE. Genetic contribution to neurodevelopmental outcomes in congenital heart disease: are some patients predetermined to have developmental delay?. Curr Opin Pediatr. 2017, 29:529-33. 10.1097/MOP.0000000000000530 10.1097/mop.0000000000000530

[5]

Morton PD, Ishibashi N, Jonas RA. Neurodevelopmental abnormalities and congenital heart disease: insights into altered brain maturation. Circ Res. 2017, 120:960-77. 10.1161/CIRCRESAHA.116.309048 10.1161/circresaha.116.309048

[6]

Marino BS, Lipkin PH, Newburger JW, et al.. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012, 126:1143-72. 10.1161/CIR.0b013e318265ee8a 10.1161/cir.0b013e318265ee8a

[7]

Zamani G, Tajdini M, Ashrafi M, Shajari H, Mehdizadeh M, Zaki Dizaji M. Impact of chronic hypoxia on neurodevelopment of children with cyanotic congenital heart disease. J Iran Med Council. 2019, 2:86-91.

[8]

World Health Organization. Child malnutrition: Severe wasting among children under 5 years of age. (2022). Accessed: October 7, 2022: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3410.

[9]

Muche A, Dewau R. Severe stunting and its associated factors among children aged 6-59 months in Ethiopia; multilevel ordinal logistic regression model. Ital J Pediatr. 2021, 47:161. 10.1186/s13052-021-01110-8 10.1186/s13052-021-01110-8

[10]

Rollins CK, Newburger JW. Cardiology patient page. Neurodevelopmental outcomes in congenital heart disease. Circulation. 2014, 130:e124-6. 10.1161/CIRCULATIONAHA.114.008556 10.1161/circulationaha.114.008556

[11]

Ferentzi H, Pfitzer C, Rosenthal LM, Berger F, Schmitt KR. Long-term early development research in congenital heart disease (LEADER-CHD): a study protocol for a prospective cohort observational study investigating the development of children after surgical correction for congenital heart defects during the first 3 years of life. BMJ Open. 2017, 7:e018966. 10.1136/bmjopen-2017-018966 10.1136/bmjopen-2017-018966

[12]

Lata K, Mishra D, Mehta V, Juneja M. Neurodevelopmental status of children aged 6-30 months with congenital heart disease. Indian Pediatr. 2015, 52:957-60. 10.1007/s13312-015-0752-5 10.1007/s13312-015-0752-5

[13]

Yilmaz ZI, Genel F, Ozbek E, Erdur B, Mese T, Karaaslan U. PS-024 Neurodevelopmental examination by Bayley scale of infant development-II in children with cyanotic congenital heart disease. Arch Dis Child. 2014, 99:A119-20. 10.1136/archdischild-2014-307384.319 10.1136/archdischild-2014-307384.319

[14]

Polat S, Okuyaz C, Hallioğlu O, Mert E, Makharoblidze K. Evaluation of growth and neurodevelopment in children with congenital heart disease. Pediatr Int. 2011, 53:345-9. 10.1111/j.1442-200X.2010.03230.x 10.1111/j.1442-200x.2010.03230.x

[15]

Weinberg S, Kern J, Weiss K, Ross G. Developmental screening of children diagnosed with congenital heart defects. Clin Pediatr (Phila). 2001, 40:497-501. 10.1177/000992280104000904 10.1177/000992280104000904

[16]

Hirose Y, Ichida F, Oshima Y. Developmental status of young infants with congenital heart disease. Pediatr Int. 2007, 49:468-71. 10.1111/j.1442-200X.2007.02404.x 10.1111/j.1442-200x.2007.02404.x

[17]

Mussatto KA, Hoffmann RG, Hoffman GM, Tweddell JS, Bear L, Cao Y, Brosig C. Risk and prevalence of developmental delay in young children with congenital heart disease. Pediatrics. 2014, 133:e570-7. 10.1542/peds.2013-2309 10.1542/peds.2013-2309

[18]

Leal LS, da Silva RL, Aita KM, Monteiro RP, de Montalvão TC. Assessment of motor development of children with congenital heart disease. Int J Cardiovasc Sci. 2016, 29:10.5935/2359-4802.20160017 10.5935/2359-4802.20160017

Metrics

5

Citations

18

References

Details

Published: Jan 04, 2023

Authors

Cite This Article

Keta Vagha, Amar Taksande, Sneha Kenjale, et al. (2023). Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study. Cureus. https://doi.org/10.7759/cureus.33373

Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study

You May Also Like